Tenaya Therapeutics Inc [NASDAQ: TNYA] price surged by 10.19 percent to reach at $0.21.
The one-year TNYA stock forecast points to a potential upside of 88.32. The average equity rating for TNYA stock is currently 1.00, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guru’s Opinion on Tenaya Therapeutics Inc [TNYA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNYA shares is $19.43 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNYA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Tenaya Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 10, 2024. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on November 30, 2023, representing the official price target for Tenaya Therapeutics Inc stock. Previously, the target price had yet another raise to $25, while H.C. Wainwright analysts kept a Buy rating on TNYA stock.
The Average True Range (ATR) for Tenaya Therapeutics Inc is set at 0.31 The Price to Book ratio for the last quarter was 1.60, with the Price to Cash per share for the same quarter was set at 1.00.
TNYA Stock Performance Analysis:
Tenaya Therapeutics Inc [TNYA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.71. With this latest performance, TNYA shares gained by 18.23% in over the last four-week period, additionally sinking by -45.69% over the last 6 months – not to mention a rise of 20.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNYA stock in for the last two-week period is set at 53.74, with the RSI for the last a single of trading hit 54.67, and the three-weeks RSI is set at 52.44 for Tenaya Therapeutics Inc [TNYA]. The present Moving Average for the last 50 days of trading for this stock 2.01, while it was recorded at 2.08 for the last single week of trading, and 3.57 for the last 200 days.
Insight into Tenaya Therapeutics Inc Fundamentals:
Tenaya Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.27 and a Current Ratio set at 5.27.
Tenaya Therapeutics Inc [TNYA] Institutonal Ownership Details
There are presently around $73.75%, or 74.62%% of TNYA stock, in the hands of institutional investors. The top three institutional holders of TNYA stocks are: COLUMN GROUP LLC with ownership of 9.4 million shares, which is approximately 11.6078%. RA CAPITAL MANAGEMENT, L.P., holding 7.62 million shares of the stock with an approximate value of $$23.63 million in TNYA stocks shares; and RA CAPITAL MANAGEMENT, L.P., currently with $$20.87 million in TNYA stock with ownership which is approximately 8.3141%.
